lauric acid has been researched along with dinoprostone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
CaJacob, CA; Masters, BS; Muerhoff, AS; Ortiz de Montellano, PR; Reich, NO; Williams, DE | 1 |
Chen, J; Fu, H; Guan, X; Gui, B; Guo, Y; Hu, J; Jin, L; Li, S; Wang, J; Xu, Y; Zhang, Q; Zhang, R | 1 |
2 other study(ies) available for lauric acid and dinoprostone
Article | Year |
---|---|
Prostaglandin and fatty acid omega- and (omega-1)-oxidation in rabbit lung. Acetylenic fatty acid mechanism-based inactivators as specific inhibitors.
Topics: Animals; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Dinoprostone; Fatty Acids, Unsaturated; Isoenzymes; Kinetics; Lauric Acids; Lung; Microsomes; Mixed Function Oxygenases; Prostaglandins A; Rabbits | 1989 |
Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors.
Topics: Aniline Compounds; Animals; Arteritis; Blood Coagulation; Corticotropin-Releasing Hormone; Cyclooxygenase 2; Dinoprostone; Intercellular Adhesion Molecule-1; Lauric Acids; Male; Peptide Fragments; Pyrimidines; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Thromboangiitis Obliterans; Thromboxane B2; Urocortins | 2009 |